Results 21 to 30 of about 845,332 (165)
Journal of the Renin-Angiotensin-Aldosterone System, 2015 Objective: Previous case-control studies on the relationship between the angiotensin-converting enzyme (ACE) gene insertion/deletion (I/D) polymorphisms and coronary restenosis did not reach the same conclusion.
Haiwei Miao, H. Gong
semanticscholar +1 more source
Management of in-stent restenosis.
EuroIntervention, 2022 In-stent restenosis (ISR) remains the most common cause of stent failure after percutaneous coronary intervention (PCI). Recent data suggest that ISR-PCI accounts for 5-10% of all PCI procedures performed in current clinical practice.
F. Alfonso +4 more
semanticscholar +1 more source
BMC Medicine, 2012 Background The benefit of the coronary collateral circulation (natural bypass network) on survival is well established. However, data derived from smaller studies indicates that coronary collaterals may increase the risk for restenosis after percutaneous
Meier Pascal +8 more
doaj +1 more source
Effects of an alpha-4 integrin inhibitor on restenosis in a new porcine model combining endothelial denudation and stent placement. [PDF]
PLoS ONE, 2010 Restenosis remains the main complication of balloon angioplasty and/or stent implantation. Preclinical testing of new pharmacologic agents preventing restenosis largely rely on porcine models, where restenosis is assessed after endothelial abrasion of ...
Anne Braun +7 more
doaj +1 more source
Nanoparticle Drug- and Gene-eluting Stents for the Prevention and Treatment of Coronary Restenosis
Theranostics, 2014 Percutaneous coronary intervention (PCI) has become the most common revascularization procedure for coronary artery disease. The use of stents has reduced the rate of restenosis by preventing elastic recoil and negative remodeling.
Rui-Xing Yin, De-zhai Yang, Jinzhen Wu
semanticscholar +1 more source
Periodontitis Is Associated With Risk of Conventional Stent Restenosis: Pilot Case-Control Study
Frontiers in Dental Medicine, 2021 Objectives: Percutaneous coronary angioplasty with stent implantation has been established as the main form of treatment of atherosclerosis. However, 16 to 44% of patients may evolve with stent restenosis.
Raphael Osugue +6 more
doaj +1 more source
Pathogenetic mechanisms of repeated adverse cardiovascular events development in patients with coronary heart disease: the role of chronic inflammation [PDF]
Folia Medica, 2023 Stent restenosis is the most unfavorable complication of interventional treatment for coronary heart disease. We already know from various literature sources that the causes for stent restenosis in patients are both mechanical damage (partial opening ...
Irina Starodubtseva +2 more
doaj +3 more sources
Diagnosis and management challenges of in-stent restenosis in coronary arteries
World Journal of Cardiology, 2017 Over the course of the 3 decades, percutaneous coronary intervention (PCI) with stent implantation transformed the practice of cardiology. PCI with stenting is currently the most widely performed procedure for the treatment of symptomatic coronary ...
M. Alraies +3 more
semanticscholar +1 more source
Arquivos Brasileiros de Cardiologia, 2001 OBJECTIVE: To compare circulating plasma levels of immunoinflammatory markers in patients with known de novo coronary artery disease and patients with postangioplasty restenosis.
Alexandre Schaan de Quadros +6 more
doaj +1 more source
Pathogenetic mechanism of stented coronary arteries restenosis and the role of vasculoendothelial growth factor A [PDF]
Кардіохірургія та інтервенційна кардіологія, 2019 The contemporary issue of in-stent restenosis is reviewed in the article. The widespread use of interventional technologies for the treatment of acute and chronic forms of ischemic heart disease led to the appearance of the problem of coronary artery ...
M.P. Kopytsya +2 more
doaj +1 more source